These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10408717)
1. Prognostic factors for survival in multiple sclerosis. Lević ZM; Dujmović I; Pekmezović T; Jarebinski M; Marinković J; Stojsavljević N; Drulović J Mult Scler; 1999 Jun; 5(3):171-8. PubMed ID: 10408717 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Eriksson M; Andersen O; Runmarker B Mult Scler; 2003 Jun; 9(3):260-74. PubMed ID: 12814173 [TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. Trojano M; Avolio C; Manzari C; Calò A; De Robertis F; Serio G; Livrea P J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):300-6. PubMed ID: 7897410 [TBL] [Abstract][Full Text] [Related]
4. Course and prognosis in early-onset MS: comparison with adult-onset forms. Simone IL; Carrara D; Tortorella C; Liguori M; Lepore V; Pellegrini F; Bellacosa A; Ceccarelli A; Pavone I; Livrea P Neurology; 2002 Dec; 59(12):1922-8. PubMed ID: 12499484 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population. El-Salem K; Khader Y Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328 [TBL] [Abstract][Full Text] [Related]
6. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Kantarci O; Siva A; Eraksoy M; Karabudak R; Sütlaş N; Ağaoğlu J; Turan F; Ozmenoğlu M; Toğrul E; Demirkiran M Neurology; 1998 Sep; 51(3):765-72. PubMed ID: 9748024 [TBL] [Abstract][Full Text] [Related]
7. Natural history of secondary-progressive multiple sclerosis. Tremlett H; Yinshan Zhao ; Devonshire V Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898 [TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: clinical characteristics and disability progression in Moroccan children. Ait Ben Haddou E; Alhyan M; Aasfara J; Regragui W; Ibrahimi A; Razine R; Abouqal R; Benomar A; Yahyaoui M J Neurol Sci; 2014 Nov; 346(1-2):128-32. PubMed ID: 25216553 [TBL] [Abstract][Full Text] [Related]
9. Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later. Scott TF; Schramke CJ J Neurol Sci; 2010 May; 292(1-2):52-6. PubMed ID: 20202650 [TBL] [Abstract][Full Text] [Related]
10. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776 [TBL] [Abstract][Full Text] [Related]
11. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study. Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M; Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296 [TBL] [Abstract][Full Text] [Related]
12. Natural history of multiple sclerosis: a unifying concept. Confavreux C; Vukusic S Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308 [TBL] [Abstract][Full Text] [Related]
13. A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. Amato MP; Ponziani G; Bartolozzi ML; Siracusa G J Neurol Sci; 1999 Oct; 168(2):96-106. PubMed ID: 10526190 [TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators for long-term disability in multiple sclerosis patients. Damasceno A; Von Glehn F; Brandão CO; Damasceno BP; Cendes F J Neurol Sci; 2013 Jan; 324(1-2):29-33. PubMed ID: 23073568 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Sayao AL; Devonshire V; Tremlett H Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course? Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Mikaeloff Y; Caridade G; Assi S; Suissa S; Tardieu M Pediatrics; 2006 Sep; 118(3):1133-9. PubMed ID: 16951008 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G; J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489 [TBL] [Abstract][Full Text] [Related]
19. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients. Kerbrat A; Hamonic S; Leray E; Tron I; Edan G; Yaouanq J; Eur J Neurol; 2015 Mar; 22(3):507-e35. PubMed ID: 25515927 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. Harding KE; Liang K; Cossburn MD; Ingram G; Hirst CL; Pickersgill TP; Te Water Naude J; Wardle M; Ben-Shlomo Y; Robertson NP J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):141-7. PubMed ID: 23154123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]